NCT06679582 · Interventional trial
Luveltamab Tazevibulin (STRO-002) in Infants and Children < 12 Years of Age With Relapsed/Refractory CBFA2T3::GLIS2 AML
Overall registry status Terminated
Phase 1 · Phase 2
Conditions Acute Myeloid Leukemia (AML)
Delaware Valley sites
- Children's Hospital of Philadelphia · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory